MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
    • careers
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Beauty
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Dr. Titus Insights: NSAIDs, Flavonoids, and Autism

Dr. Titus Insights: NSAIDs, Flavonoids, and Autism

by adminTorusBrand | Oct 21, 2016 | Company News, Dr. Titus Insights, Scientific Research

This week: Many Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) are now Associated with Heart Failure Cannabis Flavonoids – Emerging Therapeutic Applications Marijuana Arrests Fall to a 20 Year Low Autism Patents Now Treating Children with Cannabis Many Non-Steroidal...
Dr. Titus Insights: U.S. Hemp Industry, UK Doctors, and Parents Using Marijuana

Dr. Titus Insights: U.S. Hemp Industry, UK Doctors, and Parents Using Marijuana

by adminTorusBrand | Oct 14, 2016 | Company News, Dr. Titus Insights, Scientific Research

This week: Study Finds Your Doctor is Probably More Worried About Your Weight than Your Marijuana Use UK to Send Foreign Doctors Home Certified Seed and CBD Hemp US Hemp Industry Take Root Why More Parents Are Starting to Use Marijuana CTE Detected on NFL Player’s Tau...
Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media

Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media

by adminTorusBrand | Sep 26, 2016 | Company News, Dr. Titus Insights, Industry Updates, Scientific Research

This week: More Clinical Evidence for Medicinal Cannabis – Australia. CDC Says Senior Citizen Falls Are on the Rise – a leading cause of injury and death on older Americans. Scientific American Says the FDA Manipulates the Media. Forbes Says Medical Marijuana Seems to...
Dr. Titus Insights: Biotechs and Cannabis

Dr. Titus Insights: Biotechs and Cannabis

by adminTorusBrand | Sep 16, 2016 | Axim Biotechnologies, Company News, Dr. Titus Insights, Kannalife Sciences, Scientific Research

This week: GW Pharma has numerous acquisition offers from bigger pharma Insys Therapeutics Spends $500,000 to defeat cannabis recreational legalization in home state, Arizona Canada to ask the US to re-think its ludicrous border policy re cannabis usage Technical 420...
Dr. Titus Insights: Cannabinoids in Acid Form Showing Therapeutic Potential

Dr. Titus Insights: Cannabinoids in Acid Form Showing Therapeutic Potential

by adminTorusBrand | Sep 13, 2016 | Company News, Dr. Titus Insights, Scientific Research

In the raw extract from the cannabis plant, be it the marijuana form, or the hemp CBD form – we find cannabinoids in their acid form, including THC-A (marijuana) and CBD-A (hemp).  Many clever and talented marijuana growers are now also growing a CBD-variety and many...
Dr. Stuart Titus: Medical Research in Cannabis

Dr. Stuart Titus: Medical Research in Cannabis

by adminTorusBrand | Sep 2, 2016 | Company News, Dr. Titus Insights, Scientific Research

Dr. Stuart Titus, President and CEO of Medical Marijuana, Inc., reviews the history of medical marijuana and outlines the body of research that has been done on cannabis thus far.   Our resident expert on cannabinoids and the endocannabinoid system, Dr. Titus...
« Older Entries

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.